Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin

Journal of Medical Microbiology

Volumn 60, Issue 3, 2011, Pages 381-383

  Hussain, Abid ^a   Kairamkonda, Venkatesh ^a   Jenkins, David Richard ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CREATINE KINASE; CREATININE; DAPTOMYCIN; FLUCLOXACILLIN; GENTAMICIN; LINEZOLID; PENICILLIN G; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BIRTH WEIGHT; BLOOD CULTURE; BODY TEMPERATURE; BRADYCARDIA; CASE REPORT; CENTRAL VENOUS CATHETER; CESAREAN SECTION; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIZYGOTIC TWINS; DRUG CLEARANCE; DRUG DOSE INCREASE; ECHOCARDIOGRAPHY; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; INJECTION SITE PUSTULE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTILOCUS SEQUENCE TYPING; NEWBORN; NEWBORN INFECTION; OXYGEN SATURATION; PARENTERAL NUTRITION; PATENT DUCTUS ARTERIOSUS; PREMATURE LABOR; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; HUMANS; INFANT, NEWBORN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 79951932614     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.027235-0     Document Type: Article

References (11)

1. Abdel-Rahman, S. M., Benziger, D. P., Jacobs, R. F., Jafri, H. S., Hong, E. F. & Kearns, G. L. (2008). Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections. Pediatr Infect Dis J 27, 330-334. (Pubitemid 351483068)
2. Carey, A. J. & Long, S. S. (2010). Staphylococcus aureus: a continuously evolving and formidable pathogen in the neonatal intensive care unit. Clin Perinatol 37, 535-546.
3. Cohen-Wolkowiez, M., Smith, P. B., Benjamin, D. K., Jr, Fowler, V. G., Jr & Wade, K. C. (2008). Daptomycin use in infants: report of two cases with peak and trough drug concentrations. J Perinatol 28, 233-234.
4. Dvorchik, B. H., Brazier, D., DeBruin, M. F. & Arbeit, R. D. (2003). Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother 47, 1318-1323. (Pubitemid 36368592)
5. Hawkey, P. M. (2008). Pre-clinical experience with daptomycin. J Antimicrob Chemother 62 (Suppl. 3), iii7-iii14.
6. Johnson, A. P., Sharland, M., Goodall, C. M., Blackburn, R., Kearns, A. M., Gilbert, R., Lamagni, T. L., Charlett, A., Ganner, M. & other authors (2010). Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland. Arch Dis Child 95, 781-785.
7. Kanafani, Z. A. & Corey, G. R. (2007). Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections. Expert Rev Anti Infect Ther 5, 177-184. (Pubitemid 46681738)
8. Lodise, T. P., Graves, J., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B. M. & Stellrecht, K. (2008). Relationship between vancomycin MIC and failure among patients with methicillinresistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 52, 3315-3320.
9. Moise, P. A., Sakoulas, G., Forrest, A. & Schentag, J. J. (2007). Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteraemia. Antimicrob Agents Chemother 51, 2582-2586. (Pubitemid 47047340)
10. Tobin, C. M., Darville, J. M., Lovering, A. M. & Macgowan, A. P. (2008). An HPLC assay for daptomycin in serum. J Antimicrob Chemother 62, 1462-1463.
11. Yoon, Y. K., Kim, J. Y., Park, D. W., Sohn, J. W. & Kim, M. J. (2010). Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. J Antimicrob Chemother 65, 1015-1018.